4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-092944
President & CEO sold 66,667 shares at $14.12 ($941,338)
- President & CEO acquired 66,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-19 | Exercise or conversion : show line 1 in the form | +66,667 | $6.46 | $430,669 | 76,667 | D |
| 2016-01-19 | Sale : show line 2 in the form | −66,667 | $14.12 | $941,338 | 10,000 | D |
| Open-market sales · 66,667 sh · avg $14.12 · $941,338 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-01-19 | Exercise or conversion : show line 3 in the form Stock Option | −66,667 | $6.46 | 2016-02-24 | 66,667 | 66,666 | D |
Loading xslF345X03/doc4.xml…